79640-70-3

Basic information

• Product Name: L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, 1-(1,1-dimethylethyl) ester
• CAS NO: 79640-70-3
• Molecular Formula: C24H30N8O5
• Molecular Weight: 510.553
• Mol File: 79640-70-3.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, 1-(1,1-dimethylethyl) ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, 1-(1,1-dimethylethyl) ester(79640-70-3)
• EPA Substance Registry System: L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, 1-(1,1-dimethylethyl) ester(79640-70-3)

Safety Data

• Hazardous Substances Data: 79640-70-3(Hazardous Substances Data)

Upstream product

• 52853-40-4 6-bromomethyl-2,4-diaminopteridine hydrobromide 
• 511544-87-9 α-tert-butyl-N-[4-(methylamino)benzoyl]-L-glutamate 
• 79640-72-5 L-glutamic acid 1-tert-butyl ester 5-methyl ester 
• 945-24-4 2,4-diamino-6-(hydroxymethyl)pteridine 
• 10541-83-0 N-methyl-p-aminobenzoic acid 
• 73978-41-3 2,4-diamino-6-(hydroxymethyl)pteridine hydrochloride 
• 19741-14-1 4-[(2,4-diaminopteridin-6-ylmethyl)methylamino]benzoic acid 
• 1499-55-4 L-glutamic acid 5-methyl ester 
• 511544-85-7 α-tert-butyl N-[4-(N-benzyloxycarbonyl-N-methyl)aminobenzoyl]-L-glutamate 
• 66891-86-9 benzyl (4-(chlorocarbonyl)phenyl)(methyl)carbamate 
• 472960-79-5 2-(4-methylamino-benzoylamino)-pentanedioic acid 1-tert-butyl ester 5-methyl ester 
• 367275-86-3 1,1-dimethylethyl 5-methyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutamate 
• 84793-07-7 Fmoc-Glu-OtBu 
• 2528-30-5 4-<<(benzyloxy)carbonyl>methylamino>benzoic acid 

Downstream Products

• 1315482-51-9 C₅₁H₇₆N₁₂O₉S 
• 1315482-56-4 C₅₃H₇₄F₆N₁₀O₁₄ 
• 1337911-97-3 C₆₀H₈₀F₆N₁₂O₈S 
• 1315482-53-1 C₂HF₃O₂*C₄₆H₆₈N₁₂O₇S 
• 1315482-54-2 C₅₅H₇₀F₆N₁₂O₈S 
• 1315482-31-5 C₅₁H₆₂F₆N₁₂O₈S 
• 1364254-02-3 C₂₈H₃₃N₉O₇ 
• 1364253-98-4 C₂₉H₃₇N₁₁O₄ 
• 1364254-00-1 C₃₉H₅₄N₁₂O₉ 

Relevant articles and documents

Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis

Methotrexate (MTX) is the standard of care in the treatment of rheumatoid arthritis (RA), a common autoimmune disease that is characterized by chronic inflammation in the synovial membrane of joints. Unfortunately, MTX suffers from high discontinuation ra

PRODRUGS ACTIVATED BY REACTIVE OXYGEN SPECIES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES AND CANCER

Prodrugs activated predominantly or exclusively in inflammatory tissue, more particularly prodrugs of methotrexate and derivatives thereof, which are selectively activated by Reactive Oxygen Species (ROS) in inflammatory tissues associated with cancer and inflammatory diseases, as well as method for preparing said prodrugs.

Multifunctional small molecules

The present invention relates to dendrimer synthesis. Specifically, the present invention relates to dendrimer compositions (e.g., scaffolds) capable of copper-free click conjugation for use in the synthesis of functionalized dendrimers, and methods of us